Friday, October 24, 2014

Hepatitis C Virus Infection as a Traumatic Experience

Hepatitis C Virus Infection as a Traumatic Experience

Mychelle Morais-de-Jesus, Renato Daltro-Oliveira, Karine Miranda Pettersen, Adriana Dantas-Duarte, Luciana Di-Domizio Amaral, Patrícia Cavalcanti-Ribeiro, Carlos Teles Santos, Maria Isabel Schinoni, Liana R. Netto, Lucas Araújo-de-Freitas, Raymundo Paraná, Ângela Miranda-Scippa, Karestan C. Koenen, Lucas C. Quarantini mail Published: October 23, 2014 •

DOI: 10.1371/journal.pone.0110529

The purpose of this study was to evaluate whether individuals consider their HCV infection to be a potentially traumatic experience. Additionally, we investigated its association with Post-Traumatic Stress Disorder (PTSD) and the impact of PTSD diagnosis on health-related quality of life (HRQoL) in HCV infected subjects.

We conducted a cross-sectional survey of 127 HCV-infected outpatients recruited at a University Hospital in Salvador, Brazil. All subjects answered an orally-administered questionnaire to gather clinical and socio-demographic data. We investigated traumatic experiences and the subject's perception of the disease using the Trauma History Questionnaire. PTSD and other psychiatric diagnoses were assessed through the Mini International Neuropsychiatric Interview-Brazilian Version 5.0.0 (M.I.N.I. PLUS). HRQoL was assessed using Short-Form 36 (SF-36).

Approximately 38.6% of the patients considered hepatitis C to be a traumatic experience. Of these, 60.7% had a PTSD diagnosis. PTSD was associated with significant impairment in quality of life for individuals in seven SF-36 domains as shown bymultivariate analysis: Role-Physical (β: −24.85; 95% CI: −42.08; −7.61), Bodily Pain (β: −19.36; 95% CI: −31.28; −7.45), General Health (β: −20.79; 95% CI: −29.65; −11.92), Vitality (β: −11.92; 95% CI: −20.74; −3.1), Social Functioning (β: −34.73; 95% CI: −46.79; −22.68), Role-Emotional (β: −26.07; 95% CI: −44.61; −7.53), Mental Health (β: −17.46; 95% CI: −24.38; −10.54).

HCV is frequently a traumatic experience and it is strongly associated with PTSD diagnosis. PTSD significantly impaired HRQoL.

Citation: Morais-de-Jesus M, Daltro-Oliveira R, Pettersen KM, Dantas-Duarte A, Amaral LD-D, et al. (2014) Hepatitis C Virus Infection as a Traumatic Experience. PLoS ONE 9(10): e110529. doi:10.1371/journal.pone.0110529
Infection with hepatitis C virus (HCV) is common throughout the world and can result in severe liver damage and failure. Worldwide, the most common route of HCV transmission is intravenous drug use. The main risk factors in Brazil are blood transfusions from non-tested blood donors, intravenous drug use, and invasive therapies with contaminated equipment [1]. Additional risk factors of HCV infection include perinatal infection, sexual transmission and activities with potential exposure to blood, such as tattoo and piercing. The disease can manifest in a wide spectrum of effects, ranging from various degrees of liver damage, syndromes of immunological origin — such as rheumatoid symptoms and cryoglobulinemia [2][4] — and neuropsychiatric disorders such as depression and cognitive deficits [5][12].

Psychiatric disorders are highly prevalent among HCV-infected patients, and have a well established effect on their well-being. PTSD is a common, debilitating, complex syndrome which occurs in some persons after personal exposure to a traumatic stressor or experienced by a family member or another close associate. Some of the main symptoms are intense fear, helplessness, persistent avoidance of stimulus associated with the trauma, increased arousal. [13]. “The full symptom picture must be present for over 1 month (Criterion E), and the disturbance must cause clinically significant distress or impairment in social, occupational, or other important areas of functioning” (DSM-IV). Populational studies show the disorder's prevalence to be around 6.8% in a study carried out in the United States [14] and 14% in another one carried out in Brazil [15]. PTSD is highly comorbid with many different medical and psychiatric illnesses and can be underestimated in non-clinical populations [15][17]. It is also associated with significantly low rates of HRQoL [18], [19]. PTSD has already been cited in HCV populations in a small number of studies, most of which were primarily focused on other specific populations, such as veterans, HIV co-infected persons, and persons on dialysis [20][25].

Patients carrying the virus usually have a lower health-related quality of life (HRQoL) when compared with a reference population [26][28], even in the absence of severe hepatic disease [29], [30]. HRQoL is a multidimensional concept embracing an individual's perception of their own well-being in terms of: physical functioning; role-physical; bodily pain; general health; vitality; social functioning; role-emotional; and mental. This concept is based on the World Health Organization's definition of health as “A state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity” [31].

The cause of the reduced HRQoL in asymptomatic HCV-infected patients is not well understood and may have a multifactorial origin. Fatigue and other symptoms of a neuropsychiatric nature, like forgetfulness, depression and difficulty concentrating, are common complaints of HCV-infected patients [5], [29]. These patients also perform more poorly on neuropsychiatric tests [5], [32], [33], suggesting the virus may act on the nervous system. Evidence of HCV replication in the central nervous system [34], [35] supports this hypothesis. HRQoL is also improved in patients who achieve sustained virological response after antiviral therapy [36][38].

Another line of research considers that personal background may affect HRQoL due to low household income, intravenous drug use, coexistent co-morbidities, knowledge of diagnosis, and other factors associated with acquiring the infection [39], [40].

Patients with a comorbid psychiatric disorder and HCV-infection are well documented to have reduced HRQoL [41], [42]. The impact of depression on HRQoL in these patients is well-investigated [43], [44]. However, the relationship between post-traumatic stress disorder (PTSD) and HCV infection, and their combined consequence on HRQoL, is not well studied.

Accordingly, this study aimed to evaluate whether HCV-infected individuals consider their HCV infection to be a potentially traumatic event, and its association with PTSD diagnoses. The secondary objective is to investigate the relationship between PTSD diagnosis and HRQoL in HCV-infected patients. We hypothesized that, among hepatitis C patients, there is a perception of hepatitis C disease as a potentially traumatic experience, as well as an association between PTSD diagnosis and poorer HRQoL.

Materials and Methods
Ethics statement
Ethical approval for this study was obtained from the local MCO – UFBA, Institutional Review Board (IRB) (protocol 14/2002) and it is in accordance with the Helsinki Declaration of 1975. Prior to any data collection and after a complete description of the research, written informed consent was obtained from the patients who agreed to participate. All subjects answered an orally-administered questionnaire to gather clinical and socio-demographic data.

Subjects and data collection
We conducted a cross-sectional survey with chronic hepatitis C outpatients from the University Hospital (Com-HUPES) – Federal University of Bahia (UFBA) between June 2009 and July 2012. We included all patients older than 18 years of age in consecutive order. A total of 127 patients diagnosed with chronic hepatitis C were enrolled in the study (men = 82, women = 45). The samples were divided into ninety-nine HCV-control subjects (78%) and twenty-eight HCV-PTSD subjects (22%).

Measurement Instruments
We used the Trauma History Questionnaire (THQ), a 24-item self-report measurement, to assess subjects' history of traumatic life events. The adaptation of the scale for Portuguese met the criteria of semantic and operational equivalences [45]. The THQ is suitable for clinical and research environments. Traumatic experiences were classified into the following categories: “crime-related events”, “general disaster and trauma”, “physical and sexual experiences”, and “other events”.
The subjects were also asked about the frequency of the event and their ages when it occurred.
In addition to the analysis of these four types of traumatic experience, subjects who answered “Yes” to question fifteen were analyzed separately: “Have you ever had a serious or life-threatening illness? If yes, please specify.” This question investigated whether the patient considered hepatitis C to be a stressful, life-threatening experience that was experienced as a potentially traumatic event, and may be associated with PTSD.

Axis I clinical syndromes were diagnosed using the Mini International Neuropsychiatric Interview-Brazilian Version 5.0.0 (M.I.N.I. PLUS), a short, structured diagnostic interview compatible with DSM-IV and ICD-10 criteria [46].

Quality of life was assessed using Short-Form 36 (SF-36) [47]. SF-36 has been used for numerous studies all over the world in order to assess quality of life, and has been translated and validated in Brazil. The scale was translated and made suitable for the socio-economic and cultural Brazilian conditions, where validity and reproducibility were demonstrated [48]. The HRQoL was measured by eight domains: physical functioning; role-physical; bodily pain; general health; vitality; social functioning; role-emotional; and mental health. The final scores in each domain were adjusted linearly from 0 to 100 via the formulas found in SF-36; a score of “0” indicates the worst health status, a score of “100” indicates the most favorable health status.

All interviews were conducted face-to-face by trained mental health professionals. Kappa index (proportion of agreement beyond probability divided by the agreement potential) was used to obtain reliability. Every patients' disorder was recorded and fulfilled the criteria, according to this tool. The Kappa index analysis among observers in the M.I.N.I. was 0.9.

Data Analysis
Statistical analysis was conducted with STATA 9.0 software. The subjects were divided into two groups according to diagnosis for post-traumatic stress disorder: HCV without PTSD symptoms (HCV-control) and HCV with a diagnosis of PTSD (HCV-PTSD). The following independent variables were selected with the objective of performing descriptive analyses between these groups: gender, age, civil state, occupation, transplant eligibility, presence of medical comorbidity, number of medical comorbidities, presence of psychiatric comorbidity and number of psychiatric comorbidities. Chi-Square and Kruskall-Wallis tests were used to compare categorical and continuous variables, respectively, between HCV-control and HCV-PTSD groups.

To evaluate whether any THQ categories or a positive response to question fifteen of THQ were independently associated with the severity of disease (determined by transplant eligibility) or a diagnosis of PTSD, the Pearson test was used.

Bivariate analyses were carried out to verify the possible differences between PTSD diagnosis and HRQoL scores through the non-parametric Pearson test. In order to control for potential confounding factors, a multivariate analysis was performed by a robust linear regression model that allowed us to estimate the increment (or decrement) yield (β) when patients with PTSD were compared with the reference group, patients with a negative PTSD diagnosis.

All tests were performed using the significance level of 5% (p≤0.05).

The HCV-control group was predominantly male (68.7%), ranging in age from 23 to 68 years (mean = 53±8.8); most subjects had a stable partner (64.65%); over 69% had a paid occupation; 49% were eligible for a liver transplant; 44.1% had some decompensated or systemic medical comorbidity; and 50% had a psychiatric comorbidity (Table 1). On the other hand, the HCV-PTSD group had a balanced gender variable (14 male and 14 female), and ranged in age from 28 to 65 years (mean = 52±9.27); 53.57% were in a civil partnership; most had a paid occupation (75%); 78.57% were not eligible for a transplant; 42.86% had a decompensated or systemic medical comorbidity; and 71.43% had another psychiatric comorbidity. Significant differences between groups were found through bivariate analysis on the variables: civil state (p = 0.03) and number of psychiatric comorbidities (p = 0.002) (Table 1).

Table 1. Socio-demographic and clinical characteristics.

The experiences of: “crime-related events,” “general disaster and trauma,” and “other events” showed no significant association with the development of PTSD diagnosis, unlike “physical and sexual experiences,” which showed a significant association (p = 0.019). Of all subjects, 38.6% considered hepatitis C to be a traumatic experience. Of these, 60.7% had a PTSD diagnosis. The perception of hepatitis C as a traumatic experience was not associated with disease severity (needing a transplant), however it showed a significant association with diagnosis of PTSD (p = 0.003).

Bivariate analysis revealed a negative impact of PTSD symptoms in the following SF-36 domains: role-physical, bodily pain, general health, vitality, social functioning, role-emotional and mental health. Multivariate analysis reported a negative association in the following domains: role-physical, bodily pain, general health, vitality, social functioning, role-emotional and mental health, that remained significant even after adjusting for confounding factors (Table 2).

Table 2. Bivariate and Multivariate Analysis of PTSD diagnosis and Quality of Life in Chronic Hepatitis C Patients.

DiscussionFor our knowledge, this is the first study demonstrating HCV as a traumatic experience strongly associated with PTSD. The prevalence of PTSD in this sample was 28%, which is extremely high compared to mean prevalence in the general world population, ranging from 0% to 10.4% [49]. A recent survey carried out in Brazil, in the two largest cities in the country, São Paulo and Rio de Janeiro, has estimated the prevalence of PTSD in one year to range between 1.2% and 7.8% [50].
Our finding that a high proportion of HCV patients considered the condition to be a potentially traumatic experience is consistent with previous studies investigating severe acute respiratory syndrome (SARS) [51] and myocardial infarction [52], which are both recognized as potentially traumatic events that may lead to post-traumatic stress syndrome. However, one limitation of the survey is that the trauma can be influenced by the fear of death or stress of living with an illness, since the question “Have you ever had a serious or life-threatening illness?” can be interpreted differently by each patient.

The disease severity was not significantly associated with either the perception of hepatitis C as a traumatic experience or PTSD diagnosis. Contrary to our expectations, disease severity showed a tendency of negative association with PSTD diagnosis. This unexpected result is possibly related to the small sample size, and requires further investigation.

Even after adjusting for psychiatric comorbidities, PTSD was associated with quality of life scores significantly lower in seven of the eight SF-36 domains, as shown by bivariate and multivariate analysis. Similar results were found in other studies that analyzed quality of life in individuals diagnosed with PTSD symptoms [53], [54], including individuals with a past diagnosis of non-recurring PTSD [55]. Therefore, PTSD is related to impaired mental and physical health as well as increased healthcare utilization [56].

Consistent with other studies [57], there was a higher prevalence of PTSD diagnosis in female subjects (45.16%) compared to males (20.58%). The prevalence of psychiatric disorders in both HCV-control and HCV-PTSD groups was high, especially the latter, which is in accordance with previous clinical studies regarding individuals infected with hepatitis C [10], [43]. The HCV-PTSD samples had a prevalence of psychiatric disorders 49% higher on average than the general Brazilian population, according to estimates from epidemiological studies of the general population [58]. Although the majority of the studies relating PTSD to HCV patients has been conducted with veterans and HIV co-infected patients, this study had only two HIV co-infected patients and no veterans.

The mode of HCV contraction is potentially an important variable to explain some of the trauma; therefore it is important to highlight that a previous study in the population of Bahia, Brazil, found that the most common route of HCV infection is through unscreened blood transfusions [42].
Furthermore, none of the patients cited it as a traumatic experience when they were asked about the history of potentially traumatic experiences through the Trauma History Questionnaire.

The findings of this study should be interpreted with consideration of the following methodological limitations: the cross-sectional design may cause bias for assessment of other psychiatric correlations with PTSD. Since stigmatization is an important phenomenon in the HCV-infected population [59][61], patients may, as an avoidance behavior, under-report their psychopathology. The study design also made it impossible to know whether the perception of HCV as a traumatic experience was impacted by pre-existing PTSD, or was the source of the PTSD itself. Finally, the small sample size of this study may limit the power to detect association factors with moderate strength.

This study contributes to HCV being perceived as a traumatic experience and, furthermore, reveals a high prevalence of PTSD among HCV-infected patients. Our findings show that considering a subject's perception of HCV as a traumatic experience may help to detect PTSD; a condition with significant HRQoL impairment.

The authors thank all the patients who agreed to be included in this study for their cooperation. We are also grateful to Clarissa Rocha Leite, Sofia Senna-Gonçalves and Rafaela A. Lima for their technical assistance. We thank Dr. Carmine Pariante who kindly reviewed this manuscript.

Author Contributions
Conceived and designed the experiments: MMJ RDO KMP ADD LDA PCR CTS MIS LRN LAF RP AMS KCK LCQ. Performed the experiments: MMJ RDO KMP ADD LDA CTS LCQ. Analyzed the data: MMJ RDO CTS KCK LCQ. Wrote the paper: MMJ RDO PCR LRN LAF RP AMS KCK LCQ.

  1. 1. Martins T, Narciso-Schiavon JL, Schiavon LL (2010) Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 2011 57(1): 105–110. doi: 10.1016/s2255-4823(11)70024-8
  2. 2. Seeff LB, Hoofnagle JH (2003) Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. Clin Liver Dis7(1): 261–87. doi: 10.1016/s1089-3261(02)00078-8
  3. 3. Ramos-Casals M, Font J (2005) Extra hepatic manifestations in patients with chronic hepatitis C virus infection. CurrOpinRheumatol 17(4): 447–55.
  4. 4. Amodio P, Salari L, Montagnese S, Schiff S, Neri D, et al. (2012) Hepatitis C virus infection and health-related quality of life. World J Gastroenterol 18(19): 2295. doi: 10.3748/wjg.v18.i19.2295
  5. 5. Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, et al. (2005) A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 19 Suppl 3S53–63. doi: 10.1097/01.aids.0000192071.72948.77
  6. 6. Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, et al. (2005) Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 43(4): 614–22. doi: 10.1016/j.jhep.2005.04.006
  7. 7. Golden J, O'Dwyer AM, Conroy RM (2005) Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. GenHospPsychiatry 27(6): 431–8. doi: 10.1016/j.genhosppsych.2005.06.006
  8. 8. Quarantini LC, Miranda-Scippa A, Batista-Neves S, Powell VB, Abreu N, et al. (2009) A neuropsychological study comparing patients infected with HCV and HBV without psychiatric comorbidities. J Med Virol 81(7): 1184–8. doi: 10.1002/jmv.21508
  9. 9. Quarantini LC, Miranda-Scippa A, Rocha M, Bressan RA (2008) Neuropsychological function in patients with chronic hepatitis C. Liver Int 28(6): 893–4. doi: 10.1111/j.1478-3231.2008.01719.x
  10. 10. Batista-Neves SC, Quarantini LC, de Almeida AG, Bressan RA, Lacerda AL, et al. (2008) High frequency of unrecognized mental disorders in HCV-infected patients. Gen Hosp Psychiatry 30(1): 80–2. doi: 10.1016/j.genhosppsych.2007.08.014
  11. 11. Quarantini LC, Cruz SC, Batista-Neves SC, Paraná R, Miranda-Scippa A, et al. (2006) Psychosis during peginterferon-alpha 2a and ribavirin therapy: case report. Braz J InfectDis 10 (6): 406–7. doi: 10.1590/s1413-86702006000600010
  12. 12. Quarantini LC, Miranda-Scippa A, Paraná R, Sampaio AS, Bressan RA (2007) Acutedystoniaafterinjectionofpegylatedin​terferonalpha-2b. MovDisord 22(5): 747–8. doi: 10.1002/mds.21302
  13. 13. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders Fourth Edition. Washington, DC: American Psychiatric Association.
  14. 14. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, et al. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. ArchGenPsychiatry 62(6): 593. doi: 10.1001/archpsyc.62.6.593
  15. 15. Netto LR, Cavalcanti-Ribeiro P, Pereira JL, Nogueira JF, Santos LL, et al. (2013) Clinical and socio-demographic characteristics of college students exposed to traumatic experiences: a census of seven college institutions in Northeastern Brazil. PLoS One Nov 13 8(11): e78677. doi: 10.1371/journal.pone.0078677
  16. 16. Cavalcanti-Ribeiro P, Andrade-Nascimento M, Morais-de-Jesus M, de Medeiros GM, Daltro-Oliveira R, et al. (2012) Post-traumatic stress disorder as a comorbidity: impactondiseaseoutcomes. Expert RevNeurother 12(8): 1023–37. doi: 10.1586/ern.12.77
  17. 17. Scott KM, Koenen KC, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, et al. (2013) Associations between Lifetime Traumatic Events and Subsequent Chronic Physical Conditions: A Cross-National, Cross-Sectional Study. PLoS One 8(11): e80573. doi: 10.1371/journal.pone.0080573
  18. 18. Chopra MP, Zhang H, Kaiser AP, Moye JA, Llorente MD, et al. (2012) PTSD Is a Chronic, Fluctuating Disorder Affecting the Mental Quality of Life in Older Adults. Am J Geriatr Psychiatry. In press
  19. 19. Giacco D, Matanov A, Priebe S (2013) Symptoms and Subjective Quality of Life in Post-Traumatic Stress Disorder: A Longitudinal Study. PLoS One 8(4): e60991. doi: 10.1371/journal.pone.0060991
  20. 20. Tassiopoulos K, Bernstein J, Bernstein E (2013) Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study. Addict SciClinPract 13 8(1): 20. doi: 10.1186/1940-0640-8-20
  21. 21. Papić N, ŽidovecLepej S, Kurelac I, Čajić V, Budimir J, et al. (2011) Treatment of chronic hepatitis C in Croatian war veterans: experiences from Croatian reference center for viral hepatitis. Croat Med J 52(1): 35–40. doi: 10.3325/cmj.2011.52.35
  22. 22. Oser M, Cucciare M, McKellar J, Weingardt K (2012) Correlates of hazardous drinking among Veterans with and without hepatitis C. J Behav Med [Epub ahead of print]
  23. 23. Pantalone DW, Hessler DM, Bankoff SM, Shah BJ (2012) Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men. J Behav Med 35(5): 520–8. doi: 10.1007/s10865-011-9381-1
  24. 24. Dieperink E, Leskela J, Dieperink ME, Evans B, Thuras P, et al. (2008) The effect of pegylated interferon-alpha2b and ribavirin on posttraumatic stress disorder symptoms. Psychosomatics 49(3): 225–9. doi: 10.1176/appi.psy.49.3.225
  25. 25. Butt AA, Evans R, Skanderson M, Shakil AO (2006) Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis. J Hepatol 44(5): 864–8. doi: 10.1016/j.jhep.2006.01.024
  26. 26. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, et al. (2005) Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 41(4): 790–800. doi: 10.1002/hep.20659
  27. 27. Strauss E, Dias Teixeira MC (2006) Quality of life in hepatitis C. Liver Int 26(7): 755–65. doi: 10.1111/j.1478-3231.2006.01331.x
  28. 28. Bonkovsky HL, Woolley JM (1999) Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 29(1): 264–70. doi: 10.1002/hep.510290124
  29. 29. Foster GR (2009) Quality of life considerations for patients with chronic hepatitis C. J Viral Hepat 16(9): 605–11. doi: 10.1111/j.1365-2893.2009.01154.x
  30. 30. Foster GR, Goldin RD, Thomas HC (1998) Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27(1): 209–12. doi: 10.1002/hep.510270132
  31. 31. World Health Organization (2004) Promoting Mental Health: concepts Emergin evidence Practice. In: Department of Mental Health and Substance Abuse in collaboration with the Victorian Health Promotion Foundation and The University of Melbourne. Geneva.
  32. 32. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W (2003) Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J IntNeuropsycholSoc 9(6): 847–54. doi: 10.1017/s1355617703960048
  33. 33. Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, et al. (2003) Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 39(2): 231–8. doi: 10.1016/s0168-8278(03)00189-2
  34. 34. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, et al. (2002) Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76(2): 600–8. doi: 10.1128/jvi.76.2.600-608.2002
  35. 35. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78(10): 5170–83. doi: 10.1128/jvi.78.10.5170-5183.2004
  36. 36. Daltro-Oliveira R, Morais-de-Jesus M, Pettersen KM, Parana R, Quarantini LC (2013) Impact of sustained virologic response on quality of life in chronic HVC carriers. Ann Hepatol 12(3): 399–407.
  37. 37. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, et al. (2007) Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol 46(3): 420–31. doi: 10.1016/j.jhep.2006.10.009
  38. 38. Quarantini LC, Miranda-Scippa A, Batista-Neves S, Galvao-de-Almeida A, Lacerda AL, et al. (2008) The effect of early virological response in health-related quality of life in HCV-infected patients. J Med Virol 80(3): 419–23. doi: 10.1002/jmv.21094
  39. 39. Helbling B, Overbeck K, Gonvers JJ, Malinverni R, Dufour JF, et al. (2008) Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut 57(11): 1597–603. doi: 10.1136/gut.2007.142844
  40. 40. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N (1999) The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 30(5): 1299–301. doi: 10.1002/hep.510300504
  41. 41. Lim JK, Cronkite R, Goldstein MK, Cheung RC (2006) The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life. J ClinGastroenterol 40(6): 528–34. doi: 10.1097/00004836-200607000-00012
  42. 42. Batista-Neves S, Quarantini LC, Galvao-de Almeida A, Cardeal M, Lacerda AL, et al. (2009) Impact of psychiatric disorders on the quality of life of brazilian HCV-infected patients. Braz J Infect Dis 13(1): 40–3. doi: 10.1590/s1413-86702009000100009
  43. 43. Navinés R, Castellví P, Moreno-España J, Gimenez D, Udina M, et al. (2012) Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health Questionnaire. J AffectDisord 138(3): 343–51. doi: 10.1016/j.jad.2012.01.018
  44. 44. Gallegos-Orozco JF, Fuentes AP, Argueta JG, Pérez-Pruna C, Hinojosa-Becerril C, et al. (2003) Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 34(2): 124–9. doi: 10.1016/s0188-4409(03)00003-1
  45. 45. Fiszman A, Cabizuca M, Lanfredi C, Figueira I (2005) The cross-cultural adaptation to Portuguese of the Trauma History Questionnaire to identify traumatic experiences. RevBrasPsiquiatr 27(1): 63–6. doi: 10.1590/s1516-44462005000100014
  46. 46. Amorim P (2000) Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr 22: 106–15. doi: 10.1590/s1516-44462000000300003
  47. 47. Ware JE, Gandek B (1994) The SF-36 Health Survey: Development and use in mental health research and the IQOLA Project. Int J Ment Health.
  48. 48. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol 39(3): 143–50.
  49. 49. Ayuso-Mateos JL (2002) Global Burden of post-traumatic stress disorder in the year 2000: version 1 estimates. World Health Organ.
  50. 50. Ribeiro WS, Mari Jde J, Quintana MI, Dewey ME, Evans-Lacko S, et al. (2013) The impact of epidemic violence on the prevalence of psychiatric disorders in Sao Paulo and Rio de Janeiro, Brazil. PLoS One 8(5): e63545. doi: 10.1371/journal.pone.0063545
  51. 51. Mak IWC, Chu CM, Pan PC, Yiu MGC, Ho SC, et al. (2010) Risk factors for chronic post-traumatic stress disorder (PTSD) in SARS survivors. Gen Hosp Psychiatry 32(6): 590–8. doi: 10.1016/j.genhosppsych.2010.07.007
  52. 52. Ginzburg K, Ein-Dor T (2011) Posttraumatic stress syndromes and health-related quality of life following myocardial infarction: 8-year follow-up. Gen Hosp Psychiatry 33(6): 565–71. doi: 10.1016/j.genhosppsych.2011.08.015
  53. 53. Bras M, Milunović V, Boban M, Mićković V, Loncar Z, et al. (2011) A Quality of Life in Chronic Combat Related Posttraumatic Stress Disorder - A Study on Croatian War Veterans. CollAntropol 35(3): 681–6.
  54. 54. Goenjian AK, Roussos A, Steinberg AM, Sotiropoulou C, Walling D, et al. (2011) Longitudinal study of PTSD, depression, and quality of life among adolescents after the Parnitha earthquake. J Affect Disord 133(3): 509–15. doi: 10.1016/j.jad.2011.04.053
  55. 55. Westphal M, Olfson M, Gameroff MJ, Wickramaratne P, Pilowsky DJ, et al. (2011) Functional impairment in adults with past posttraumatic stress disorder: findings from primary care. Depress Anxiety 28(8): 686–95. doi: 10.1002/da.20842
  56. 56. Glaesmer H, Braehler E, Riedel-Heller SG, Freyberger HJ, Kuwert P (2011) The association of traumatic experiences and posttraumatic stress disorder with health care utilization in the elderly-a German population based study. Gen Hosp Psychiatry 33(2): 177–84. doi: 10.1016/j.genhosppsych.2010.12.006
  57. 57. Stein MB, Walker JR, Forde DR (2000) Gender differences in susceptibility to posttraumatic stress disorder. Behav Res Ther 38(6): 619–28. doi: 10.1016/s0005-7967(99)00098-4
  58. 58. World Health Organization and World Organization of Family Doctors (Wonca) (2008) Integrating mental health into primary care - a global perspective. Singapurep. 89.
  59. 59. Zaidi MA, Griffiths R, Newson-Smith M, Levack W (2012) Impact of stigma, culture and law on healthcare providers after occupational exposure to HIV and hepatitis C. Cult Health Sex 14(4): 379–91. doi: 10.1080/13691058.2011.646304
  60. 60. Fry M, Bates G (2012) The tasks of self-managing hepatitis C: The significance of disclosure. Psychol Health 27(4): 460–74. doi: 10.1080/08870446.2011.592982
  61. 61. Lekas HM, Siegel K, Leider J (2011) Felt and Enacted Stigma Among HIV/HCV-Coinfected Adults. Qual Health Res 21(9): 1205–19. doi: 10.1177/1049732311405684

No comments:

Post a Comment